Testing the Water – Urine Test Identifies Babies at Most Risk of Necrotizing Enterocolitis
News Apr 16, 2013
Babies who later went on to develop NEC had a lower diversity of gut bacteria 4-9 days after birth, increased level of Firmicutes or Enterobacteriaceae, and lacked the Propionibacterium found in healthy babies.
NEC is a common but devastating problem of premature babies - affecting about 10% of infants born at under 29 weeks, about a third will die. To find out what the difference is between babies who have NEC and those who do not, 35 premature babies from Cincinnati Children’s Hospital Medical Center were investigated. In this study, which also involved researchers from Boston College, Miami University, and Broad Institute, eleven of the babies went on to develop NEC.
Babies who went on to develop NEC had a lower diversity of gut organisms between days 4-9 after birth. All of the babies with NEC also had unusual levels of specific bacteria. Babies whose NEC started early (between 7-12 days after birth) had abnormally high levels of Firmicutes while babies whose NEC started later (19-31 days) had high levels of Enterobacteriaceae. All of the affected babies lacked Propionibacterium usually found in healthy babies.
The bacterial levels in this study were analysed from stool samples. But bacterial levels in the gut can also be determined indirectly from urine. Prof Ardythe Morrow, who led this study explained, “Our data show that onset of NEC appears to be related to having abnormally high levels of specific bacteria in the gut during the first week or two of life. Our data also indicate that a simple urine test looking at levels of alanine and histidine, which appear altered by these bacteria, can be used early in life to identify babies at risk of NEC.”
To make sure that these findings apply to preterm infants in general, the research team is now studying hundreds of infants in multiple hospitals.
IDEX Health & Science Announces Acquisition of New Microfluidics CompanyNews
IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.READ MORE
Breath Test Could Simplify Drug and Disease TestingNews
Testing for drug use and disease in humans could soon be much simpler, thanks to new Swedish research.Scientists have demonstrated how collecting and analysing externally-produced compounds in the lining fluid of the airways allows for non-invasive testing and monitoring.The researchers used liquid chromatography-mass spectrometry to analyse the collected samples, as well as investigating the impact of different breathing patterns.READ MORE
Smartphone Case Offers Blood Glucose Monitoring on the GoNews
Engineers at the University of California San Diego have developed a smartphone case and app that could make it easier for patients to record and track their blood glucose readings, whether they’re at home or on the go.READ MORE